Evidence map›Paper›PMID 39448418›Full record

ArticleEuropean radiology2025

The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography.

Yi Chen, Tiansong Xie, Lei Chen, Zehua Zhang, Yu Wang, Zhengrong Zhou, Wei Liu

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi Chen *Department of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Tiansong Xie *Department of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Lei ChenDepartment of Radiology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, 201100, China.
Zehua ZhangDepartment of Radiology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, 201100, China.
Yu WangClinical and Technical Support, Philips Healthcare, Shanghai, 200072, China.
Zhengrong ZhouDepartment of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. zhouzr-16@163.com.
Wei LiuDepartment of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. lw02017@163.com.ORCID http://orcid.org/0000-0003-3789-8953

Funding

Artificial Intelligence Medical Hospital Cooperation Project of Shanghai Xuhui District Science and Technology 23XHYD-13Science and Technology Innovation Plan Of Shanghai Science and Technology Commission 22490760800Shanghai Anticancer Association Eyes Project SACACY23B05Shanghai Anticancer Association Soar Project SACAAX202309
6 · The paper itself

Abstract

objectivesTo investigate the value of dual-layer spectral computed tomography (DLCT) parameters derived from primary tumors in predicting lymph node metastasis (LNM) of resectable pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND

methodsIn this retrospective study, patients with resectable PDAC who underwent DLCT within 2-week intervals before surgery were enrolled and randomly divided into training and validation sets at a 7:3 ratio. The patients' clinical data, CT morphological features, and DLCT parameters were analyzed. Univariate and multivariate logistic analyses were used to identify the predictors and construct a predictive model, and receiver operator characteristic (ROC) curves were programmed to evaluate the predictive efficacy.

resultsWe enrolled 107 patients (44 patients with LNM and 63 patients without LNM). Among all variables, iodine concentration in the venous phase, extracellular volume, and tumor size were identified as independent predictors of LNM. The nomogram model, incorporating the two DLCT parameters and the morphological feature, achieved an area under the curve (AUC) of 0.877 (95% confidence interval [CI]: 0.803-0.952) and 0.842 (95% CI: 0.707-0.977) for predicting LNM in the training and validation sets, respectively. Furthermore, the AUC of the nomogram model was greater than that of morphological features of lymph nodes in the training (AUC = 0.877 vs. 0.570) and validation (AUC = 0.842 vs. 0.583) sets.

conclusionsDLCT has the potential to predict LNM in patients with resectable PDAC and show a better predictive value than morphological features of lymph nodes. KEY POINTS: Question Morphological features of lymph nodes are of limited value in detecting metastatic lymph nodes in pancreatic ductal adenocarcinoma (PDAC). Findings Dual-layer spectral computed tomography (DLCT) parameters and morphological features derived from PDAC lesions show good preoperatively predictive efficacy for lymph node metastasis. Clinical relevance The proposed DLCT-based nomogram model may serve as an effective and convenient tool for preoperatively predicting lymph node metastasis of resectable PDAC.

Indexed as

Carcinoma, Pancreatic DuctalLymphatic MetastasisPancreatic NeoplasmsTomography, X-Ray ComputedAdultAgedAged, 80 and overContrast MediaFemaleHumansLymph NodesMaleMiddle AgedNomogramsPredictive Value of TestsPreoperative CareContrast MediaDual-layer spectral CTLymph node metastasisNomogramPancreatic ductal adenocarcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.